ALX Oncology Inc. (ALXO)

AI Score

Unlock

0.54

-0.06 (-10.15%)

At close: Apr 25, 2025, 3:21 PM

ALX Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	17.57M	16.1M	15.53M	14.04M	22.41M	19.58M	38.04M	63.19M	282.91M	49.05M	66.38M	159.09M	363.67M	385.15M	409.96M	429.86M	434.22M	259.48M	98.1M	105.03M	9.02M	-8.26M
Short-Term Investments	110.19M	132.47M	141.19M	143.4M	160.33M	170.43M	174.8M	164.75M	217.38M	235.85M	246.99M	157.51M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.52M
Long-Term Investments	3.52M	14.04M	29.54M	27.11M	35.48M	6.43M	11.65M	28.22M	16.7M	8.22M	10.86M	25.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	267K	5.47M	5.66M	7.43M	7.58M	4.79M	5.66M	7.83M	9.01M	10.03M	10.08M	10.07M	9.69M	10.2M	8.85M	536K	1.78M	n/a	2.41M	229K	7K	-8.26M
Receivables	n/a	1.18M	6.24M	1.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	527K	527K	1.19M	536K	n/a
Inventory	n/a	25K	n/a	n/a	n/a	-7.04M	-500K	-800K	-17.7M	n/a	-900K	-600K	n/a	n/a	n/a	n/a	n/a	n/a	641K	n/a	n/a	n/a
Other Current Assets	6.59M	1.2M	315K	10.43M	5.92M	9.06M	6.72M	4.59M	4.76M	5.9M	3.48M	4.93M	3.35M	3.81M	2.31M	2.47M	1.77M	n/a	641K	n/a	n/a	n/a
Total Current Assets	134.35M	155.9M	168.71M	167.86M	188.66M	199.07M	219.56M	232.54M	270.97M	290.81M	316.85M	321.52M	367.02M	388.96M	412.28M	432.33M	434.22M	262.4M	100.66M	107.41M	9.81M	8.26M
Property-Plant & Equipment	9.63M	10.31M	10.7M	10.24M	10.84M	9.81M	9.07M	9.55M	9.81M	8.64M	8.23M	6.97M	3.47M	562K	167K	47K	52K	45K	37K	757K	860K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	13.42M	29.82M	45.91M	44.79M	53.89M	21.04M	26.37M	45.6M	35.52M	26.88M	29.17M	42.15M	13.16M	10.77M	9.01M	583K	1.83M	45K	2.45M	986K	867K	-8.26M
Total Assets	147.78M	185.72M	214.62M	212.65M	242.55M	220.11M	245.93M	278.14M	306.49M	317.69M	346.02M	363.68M	380.18M	399.73M	421.29M	432.91M	436.05M	262.45M	103.11M	108.4M	10.68M	n/a
Account Payables	4.5M	7.89M	8.15M	6.23M	8.59M	13M	4.12M	9.83M	8.07M	5.88M	8.68M	5.13M	3.76M	3.68M	5.81M	7.35M	4K	1.42M	1.86M	1.99M	3.75M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	-823K	-800K	n/a	n/a	17.35M	n/a	n/a	10.53M	8M	7.43M	6.44M	n/a	2.96M	3.84M	797K	n/a	n/a
Short-Term Debt	435K	n/a	1.74M	1.79M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.57M	1.71M	857K	n/a	n/a
Other Current Liabilities	7.88M	24.39M	24.69M	21.73M	19.77M	17.87M	10.18M	2.33M	15.5M	13.4M	10.59M	2.76M	7.5M	5.93M	5.87M	4.56M	3.98M	2.08M	3.47M	731K	1.06M	n/a
Total Current Liabilities	18.5M	32.34M	38.45M	32.23M	36M	35.14M	17.57M	21.89M	28.32M	25.24M	23.95M	15.31M	15.29M	12.49M	13.98M	14.13M	6.2M	7.2M	7.72M	3.99M	4.98M	n/a
Long-Term Debt	9.47M	9.84M	9.77M	9.7M	9.64M	9.57M	9.51M	9.45M	9.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.19M	3.93M	4.67M	5.42M	n/a
Other Long-Term Liabilities	6.19M	6.73M	1.12M	1.17M	1.22M	6.64M	6.16M	6.41M	5.31M	n/a	5.75M	4.77M	1.84M	n/a	2.3M	297K	5K	47K	820K	620K	547K	n/a
Total Long-Term Liabilities	15.66M	16.57M	16.85M	16.23M	16.84M	16.21M	15.67M	15.86M	14.7M	5.48M	5.75M	4.77M	1.84M	2.07M	2.3M	297K	5K	3.24M	4.75M	5.29M	5.97M	n/a
Total Liabilities	34.16M	48.91M	55.3M	48.45M	52.84M	51.35M	33.24M	37.75M	43.02M	30.73M	29.7M	20.08M	17.13M	14.56M	16.27M	14.43M	436.05M	10.43M	12.47M	9.28M	10.95M	n/a
Total Debt	9.9M	9.84M	17.47M	16.84M	17.2M	9.57M	9.51M	10.41M	10.43M	6.6M	1.07M	1.02M	742K	703K	539K	235K	n/a	5.76M	5.64M	5.53M	5.42M	n/a
Common Stock	53K	53K	52K	50K	50K	41K	41K	41K	41K	41K	41K	41K	41K	40K	40K	40K	40K	37K	3K	3K	3K	n/a
Retained Earnings	-621.12M	-591.96M	-561.25M	-521.85M	-486.27M	-440.8M	-389.81M	-355.65M	-325.47M	-294.76M	-259.44M	-226.52M	-201.99M	-173.55M	-148.98M	-132.71M	-118.52M	-99.75M	-89.57M	-78.24M	-72.78M	n/a
Comprehensive Income	275K	563K	-73K	28K	256K	-226K	-312K	-88K	-845K	-1.5M	-1.26M	-606K	-0.00	0.00	-0.00	-30K	0.00	-97K	-92K	-1.56M	-1.45M	-51.78M
Shareholders Equity	113.62M	136.81M	159.32M	164.19M	189.71M	-440.8M	212.69M	240.39M	-325.47M	286.96M	316.32M	343.6M	-201.99M	385.17M	405.01M	418.48M	429.85M	252.02M	90.64M	99.12M	-276K	9.15M
Total Investments	113.71M	146.51M	170.73M	170.51M	195.81M	176.86M	186.44M	192.97M	234.08M	244.07M	257.85M	182.62M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	16.52M